Blobs form during the single-file transport of proteins across nanopores.
electroosmosis
nanopore
protein sequencing
translocation
Journal
Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876
Informations de publication
Date de publication:
17 Sep 2024
17 Sep 2024
Historique:
medline:
12
9
2024
pubmed:
12
9
2024
entrez:
12
9
2024
Statut:
ppublish
Résumé
The transport of biopolymers across nanopores is an important biological process currently under investigation for the rapid analysis of DNA and proteins. While the transport of DNA is generally understood, methods to induce unfolded protein translocation have only recently been discovered (Yu et al., 2023, Sauciuc et al., 2023). Here, we found that during electroosmotically driven translocation of polypeptides, blob-like structures typically form inside nanopores, often obstructing their transport and preventing addressing individual amino acids. This is in contrast with the electrophoretic transport of DNA, where the formation of such structures has not been reported. Comparisons between different nanopore sizes and shapes and modifications by different surface chemistries allowed formulating a mechanism for blob formation. We also show that single-file transport can be achieved by using 1) nanopores that have an entry and an internal diameter smaller than the persistence length of the polymer, 2) nanopores with a nonsticky (i.e
Identifiants
pubmed: 39264741
doi: 10.1073/pnas.2405018121
doi:
Substances chimiques
Proteins
0
Peptides
0
DNA
9007-49-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2405018121Subventions
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)
ID : XL21.003
Organisme : Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)
ID : XL21.003
Déclaration de conflit d'intérêts
Competing interests statement:Giovanni Maglia has equity in and is a founder, director, and shareholder of Portal Biotech Limited, a company engaged in the development of nanopore technologies. This work was not supported by Portal Biotech Limited.